225 related articles for article (PubMed ID: 19625619)
1. Role of human noncoding RNAs in the control of tumorigenesis.
Li L; Feng T; Lian Y; Zhang G; Garen A; Song X
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12956-61. PubMed ID: 19625619
[TBL] [Abstract][Full Text] [Related]
2. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
Wang G; Cui Y; Zhang G; Garen A; Song X
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16794-8. PubMed ID: 19805375
[TBL] [Abstract][Full Text] [Related]
3. Roles of PSF protein and VL30 RNA in reversible gene regulation.
Song X; Sun Y; Garen A
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12189-93. PubMed ID: 16079199
[TBL] [Abstract][Full Text] [Related]
4. Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis.
Song X; Sui A; Garen A
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):621-6. PubMed ID: 14704271
[TBL] [Abstract][Full Text] [Related]
5. From a retrovirus infection of mice to a long noncoding RNA that induces proto-oncogene transcription and oncogenesis via an epigenetic transcription switch.
Garen A
Signal Transduct Target Ther; 2016; 1():16007. PubMed ID: 29263895
[TBL] [Abstract][Full Text] [Related]
6. The non-coding RNA llme23 drives the malignant property of human melanoma cells.
Wu CF; Tan GH; Ma CC; Li L
J Genet Genomics; 2013 Apr; 40(4):179-88. PubMed ID: 23618401
[TBL] [Abstract][Full Text] [Related]
7. Insight into the Tumor Suppression Mechanism from the Structure of Human Polypyrimidine Splicing Factor (PSF/SFPQ) Complexed with a 30mer RNA from Murine Virus-like 30S Transcript-1.
Wang J; Sachpatzidis A; Christian TD; Lomakin IB; Garen A; Konigsberg WH
Biochemistry; 2022 Sep; 61(17):1723-1734. PubMed ID: 35998361
[TBL] [Abstract][Full Text] [Related]
8. Regulatory roles of tumor-suppressor proteins and noncoding RNA in cancer and normal cell functions.
Garen A; Song X
Int J Cancer; 2008 Apr; 122(8):1687-9. PubMed ID: 18067128
[TBL] [Abstract][Full Text] [Related]
9. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.
Chen J; OuYang H; An X; Liu S
PLoS One; 2018; 13(1):e0191325. PubMed ID: 29346433
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong S; Bodescot M; Blair D; Dunn J; Nakamura T; Mizuno K; Park M; Chan A; Aaronson S; Vande Woude GF
Mol Cell Biol; 1992 Nov; 12(11):5152-8. PubMed ID: 1406687
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
[TBL] [Abstract][Full Text] [Related]
12. Role of PSF-TFE3 oncoprotein in the development of papillary renal cell carcinomas.
Mathur M; Samuels HH
Oncogene; 2007 Jan; 26(2):277-83. PubMed ID: 16832349
[TBL] [Abstract][Full Text] [Related]
13. Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF.
Figueroa A; Fujita Y; Gorospe M
Cell Cycle; 2009 Nov; 8(22):3648-51. PubMed ID: 19855157
[TBL] [Abstract][Full Text] [Related]
14. Novel roles of hakai in cell proliferation and oncogenesis.
Figueroa A; Kotani H; Toda Y; Mazan-Mamczarz K; Mueller EC; Otto A; Disch L; Norman M; Ramdasi RM; Keshtgar M; Gorospe M; Fujita Y
Mol Biol Cell; 2009 Aug; 20(15):3533-42. PubMed ID: 19535458
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of PSF, a novel pre-mRNA splicing factor.
Patton JG; Porro EB; Galceran J; Tempst P; Nadal-Ginard B
Genes Dev; 1993 Mar; 7(3):393-406. PubMed ID: 8449401
[TBL] [Abstract][Full Text] [Related]
16. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo.
Rosonina E; Ip JY; Calarco JA; Bakowski MA; Emili A; McCracken S; Tucker P; Ingles CJ; Blencowe BJ
Mol Cell Biol; 2005 Aug; 25(15):6734-46. PubMed ID: 16024807
[TBL] [Abstract][Full Text] [Related]
17. NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.
Galietta A; Gunby RH; Redaelli S; Stano P; Carniti C; Bachi A; Tucker PW; Tartari CJ; Huang CJ; Colombo E; Pulford K; Puttini M; Piazza RG; Ruchatz H; Villa A; Donella-Deana A; Marin O; Perrotti D; Gambacorti-Passerini C
Blood; 2007 Oct; 110(7):2600-9. PubMed ID: 17537995
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of met oncogene activation.
Park M; Dean M; Cooper CS; Schmidt M; O'Brien SJ; Blair DG; Vande Woude GF
Cell; 1986 Jun; 45(6):895-904. PubMed ID: 2423252
[TBL] [Abstract][Full Text] [Related]
19. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
20. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD.
Emili A; Shales M; McCracken S; Xie W; Tucker PW; Kobayashi R; Blencowe BJ; Ingles CJ
RNA; 2002 Sep; 8(9):1102-11. PubMed ID: 12358429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
